AlphaLens
Research
财报Equal-weightTP $3050.00005月12日 · Morgan Stanley

Imperial Brands 1H26: Small Miss, Steady Guidance, and the Case for a 2H Recovery

中文EN⚠ quality lint: see notes

Imperial Brands 1H26: Small Miss, Steady Guidance, and the Case for a 2H Recovery

Core Conclusion

Imperial Brands reported 1H26 adjusted operating profit and EPS approximately 1% below Visible Alpha consensus, but reaffirmed FY26 guidance. The implied second-half acceleration (operating profit growth in the mid-single to high-single-digit percent range versus flat 1H) is the central investment thesis. The stock has already de-rated roughly 10% since mid-April, suggesting buy-side expectations were already conservative. At 8.0x CY26 P/E (a ~35% discount to BAT) and a free cash flow yield above 9%, the downside is cushioned, but structural headwinds in combustibles and limited near-term NGP profitability keep the risk/reward balanced.

What the Market Is Underestimating

The consensus appears to discount the magnitude of the 2H operating profit recovery. Management explicitly cited more than £50 million in one-off headwinds in 1H — US Mass Market Cigar tariffs, Australian operating deleverage, year-end promotions in the US, and the myblu phase-out. These are temporary. Their reversal alone should lift 2H organic growth from +0.6% in 1H to the +3–5% full-year guidance band. The market also overlooks the resilience of next-generation product (NGP) growth outside the Americas: European NGP revenue rose +15.3% and AAACE +60%, while Americas declined -45.8% on myblu exit and promotional timing. Zone volumes grew more than 40%. Finally, the aggregate combustibles market share loss of -16bps across the top five markets is already embedded in the current valuation; further erosion would need to accelerate materially to justify the 35% discount to BAT.

Evidence Chain

1H26 Results Slightly Below Consensus, but Guidance Reaffirmed. Reported adjusted operating profit was £1,644 million versus consensus £1,664 million (-1.2%). Adjusted EPS came in at 126.9p versus 128.3p (-1.1%). On an organic constant-currency basis, operating profit grew only +0.6% in 1H. Yet full-year guidance for operating profit growth of +3–5% and EPS growth above high-single-digit percent was reiterated. Achieving the midpoint of that range requires 2H organic growth of approximately +MSD/HSD%, a sharp inflection from the first half.

Combustibles Share Losses Are Broad but Concentrated. Aggregate market share declined 16bps across the top five markets: US -20bps, UK -55bps, Spain -20bps, Australia -55bps, and Germany +5bps. In the US, premium brands Winston and KOOL gained share, but the deep-discount segment expanded, pressuring overall mix. Volume declines of -1.5% in 1H were partly offset by price/mix of +3.0%, though this was down from +6.2% in 1H25. The rate of share erosion is well known and already reflected in the stock’s de-rating.

NGP Shows Regional Strength Despite Americas Drag. Total NGP net revenue increased +7.5% on a constant-currency basis, slightly below consensus of +1.9% for tobacco and NGP combined. Europe grew +15.3% and AAACE +60%, while Americas declined -45.8% due to myblu removal and £13 million in year-end promotions. Zone volume continued to scale, growing more than 40%, and new flavour launches are expected to drive a stronger 2H. NGP adjusted operating profit was a loss of -£40 million, up modestly from -£37 million in 1H25. The path to NGP profitability remains slow, but the trajectory outside the US is encouraging.

Strong Free Cash Flow and Balance Sheet Support Capital Returns. Trailing 12-month free cash flow reached £2.6 billion, up £0.2 billion from 1H25, with cash conversion of 98%. Net debt to EBITDA remained stable at 2.4x. A £1.45 billion share buyback programme is underway, with the majority expected to be completed during FY26. The interim dividend was increased 4.0%, contrasting with consensus expectations of a -3.6% decline. The combination of >9% free cash flow yield and 2.4x leverage provides a meaningful floor under the equity.

Middle-East Conflict Impact Limited to Date. Management noted that while the conflict has created macroeconomic uncertainty, it has not materially affected operations. The longer it persists, the more likely input costs and duty-free demand could be affected. This is a manageable tail risk for now.

Key Risks

  • Accelerated market share erosion in the US, UK, Spain, and Australia as consumer downtrading and deep-discount growth persist. While current share losses are priced in, an inflection toward faster losses would compress valuation further.
  • Adverse regulatory changes or excise tax increases that reduce volume and pricing power. The UK and EU regulatory environment remains unpredictable.
  • Prolonged US NGP transition. The myblu exit and slow recovery in Americas NGP profitability could push breakeven further out, delaying the broader NGP story.
  • Failure to deliver 2H guidance. If the one-off reversals do not materialize as expected, the 2H acceleration could fall short, undermining the thesis.
  • Input cost or duty-free disruption from an extended Middle-East conflict. This is a secondary risk but could compound other headwinds.

Valuation and Trade Implication

At the current price of 2,728p, the stock offers approximately 12% upside to the price target of 3,050p. The target is derived from a blended DCF valuation (WACC 8.5%, terminal growth -4.5%) yielding 3,185p, and a multiple-based approach applying roughly 9x FY26 EPS to reach 2,900p. The Equal-weight rating reflects balanced risk/reward. Key catalysts for re-rating include 2H results demonstrating the predicted acceleration, NGP profitability improvement, and continued capital returns. Downside protection comes from a 2.4x leverage ratio, a free cash flow yield above 9%, and a ~35% valuation discount to BAT that already embeds considerable pessimism. Investors positioned for a 2H recovery should monitor monthly volume data and NGP trends in Europe; those seeking safety should note the dividend yield and buyback as near-term income support.


Appendix: 1H26 Results vs Consensus (Key Line Items)

Metric1H26 ActualConsensusΔ (%)
Adj. Operating Profit (£m)1,6441,664-1.2%
Adj. EPS (p)126.9128.3-1.1%
Tobacco & NGP Net Revenue (£m)3,7293,691+1.0%
NGP Revenue (£m)176177-0.4%
Tobacco Volume (bn sticks)8685+1.3%
LTM Free Cash Flow (£bn)2.6

Related (同 ticker)